Long-Term Treatment With Mavacamten and Improved Left Atrial Strain in Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Lee, Hyun-Jung [1 ]
Hong, Geu-Ru [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源：
JACC-CARDIOVASCULAR IMAGING | 2025年 / 18卷 / 03期
关键词：
hypertrophic cardiomyopathy; left atrial strain; mavacamten; myocardial deformation; myosin inhibitor; MYECTOMY;
D O I：
10.1016/j.jcmg.2024.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [31] LONG-TERM FOLLOW UP AFTER SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    ROTHLIN, M
    ARBENZ, U
    KRAYENBUHL, HP
    TURINA, J
    SENNING, A
    ZEITSCHRIFT FUR KARDIOLOGIE, 1976, 65 (06): : 501 - 510
  • [32] LONG-TERM TREATMENT OF HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY (HNCM) WITH VERAPAMIL
    KUHN, H
    THELEN, U
    LEUNER, C
    KOHLER, E
    BLUSCHKE, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1980, 69 (10): : 669 - 675
  • [33] Interventional treatment of patients with hypertrophic obstructive cardiomyopathy: the immediate and long-term results
    Sieraia, A.
    Nevmerzhytska, L.
    Lazoryshynets, V
    Rudenko, K.
    Romanyak, V
    Fanta, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Long-Term Clinical Value And Impact Of Mavacamten In Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Systematic Review And Meta- Analysis
    Sebastian, Sneha Annie
    Khan, Ubaid
    Padda, Inderbir
    Mahtani, Arun
    Nasir, Muhammad M.
    Mubariz, Muhammad
    Iqbal, Javed
    Johal, Gurpreet
    CIRCULATION RESEARCH, 2023, 133
  • [35] Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study
    Masri, Ahmad
    Lester, Steven J.
    Stendahl, John C.
    Hegde, Sheila M.
    Sehnert, Amy J.
    Balaratnam, Ganesh
    Shah, Ashish
    Fox, Shawna
    Wang, Andrew
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (08):
  • [36] Long-term outcome of conservative and invasive treatment in patients with hypertrophic obstructive cardiomyopathy
    Hoedemakers, Sarah
    Vandenberk, Bert
    Liebregts, Max
    Bringmans, Tijs
    Vriesendorp, Pieter
    Willems, Rik
    Van Cleemput, Johan
    ACTA CARDIOLOGICA, 2019, 74 (03) : 253 - 261
  • [37] Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy
    Azumi, Y.
    Tani, T.
    Ishibashi, K.
    Konda, T.
    Sumida, T.
    Sasaki, Y.
    Ota, M.
    Kim, K.
    Kitai, T.
    Yamane, T.
    Kobori, A.
    Ehara, N.
    Kinoshita, M.
    Kaji, S.
    Furukawa, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 275 - 275
  • [38] MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN OCTOGENARIAN
    Chandrasekhar, Sanjay Amrith
    Enciso, Juan
    Casals, Luke R.
    Wu, Robby
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2801 - 2801
  • [39] EXPLORER-HCM: mavacamten in the treatment of symptomatic hypertrophic obstructive cardiomyopathy
    Rapezzi, Claudio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (01) : 30 - 32
  • [40] LONG-TERM TREATMENT WITH VERAPAMIL FOR HYPERTROPHIC CARDIOMYOPATHY
    TROESCH, M
    HIRZEL, HO
    JENNI, R
    KRAYENBUHL, HP
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1979, 109 (43) : 1683 - 1683
12345